| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 41 |
| 1 | PREDNISONE | 39 |
| 2 | TACROLIMUS | 27 |
| 3 | BENDAMUSTINE HYDROCHLORIDE | 25 |
| 4 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 25 |
| 5 | METHOTREXATE SODIUM | 24 |
| 6 | METHOTREXATE | 23 |
| 7 | TACROLIMUS OINTMENT 0.1% | 23 |
| 8 | DARBEPOETIN ALFA | 21 |
| 9 | CYCLOPHOSPHAMIDE | 20 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OCTOCRYLENE, AVOBENZONE | 2 | 0.0045 |
| 1 | LIFILEUCEL | 1 | 0.0035 |
| 2 | BENDAMUSTINE HYDROCHLORIDE | 25 | 0.0029 |
| 3 | DEFEROXAMINE MESYLATE | 4 | 0.0018 |
| 4 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 1 | 0.0016 |
| 5 | PENICILLIN G POTASSIUM | 1 | 0.0014 |
| 6 | CUPRIC CHLORIDE | 1 | 0.0013 |
| 7 | ATENOLOL AND CHLORTHALIDONE | 1 | 0.0013 |
| 8 | BISACODYL 5MG | 1 | 0.0011 |
| 9 | PROPYLTHIOURACIL | 2 | 0.0010 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 63 |
| 1 | CD20-directed Cytolytic Antibody [EPC] | 41 |
| 2 | Kinase Inhibitor [EPC] | 28 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 23 |
| 4 | Alkylating Drug [EPC] | 22 |
| 5 | Erythropoiesis-stimulating Agent [EPC] | 21 |
| 6 | Vitamin C [EPC] | 21 |
| 7 | Vitamin B12 [EPC] | 20 |
| 8 | Vitamin D [EPC] | 20 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 18 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 1 | Erythroid Maturation Agent [EPC] | 2 | 0.0008 |
| 2 | Oxazolidinone Antibacterial [EPC] | 13 | 0.0004 |
| 3 | Erythropoiesis-stimulating Agent [EPC] | 21 | 0.0004 |
| 4 | Calcitonin [EPC] | 1 | 0.0003 |
| 5 | Iron Chelator [EPC] | 9 | 0.0003 |
| 6 | Sulfone [EPC] | 3 | 0.0003 |
| 7 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 8 | Thyroid Hormone Synthesis Inhibitor [EPC] | 2 | 0.0002 |
| 9 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |